1Jian Li,Roger L,Nation Robert W,etal.Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria[J].Inter J Antimicro Agents,2005,25:11-25.
2Stein A,Raoult D.Colistin:an antimicrobial for the 21 st century?[J].Clin Infect Dis,2002,35(7):901-902.
3Garnacho-Montero J,Ortiz-Leyba C,Jim nez-Jim nez FJ,et al.Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VIP) with intravenous colistin:a comparison with imipenem-susceptible VAP[J].Clin Infect Dis,2003,36:1111-1118.
4Reina R,Estenssoro E,Saenz G,et al.Safety and efficacy of colistin in Acinetobacter and Pseudomonas infections:a prospective cohort study[J].Intensive Care Med,2005,31(8):1058-1065.
5Peter K.linden,Shimon Kusne,Kim Coley,et al.Use of parenteral colistin for the treatment of serious infection due to antimicrobial-resistant Pseudomonas aerginasa[J].Clin Infect Dis,2003,37:154-160.
6Nikolaos Markou,Haralampos Apostolakos,Christiana Koumoudiou,et al.Intravenous colistin in the treatment ossepsis from multiresistant gram-negative bacilli in critically ill patients[J],Critical Care,2003,7(5):78-83
7Petrosillo N,Chinello P,proietti MF,Cecchini L,et al.Combined colistin and rifampicin theraly for carbapenem-resistant Acinetobacter baumannii infection:clinical outcome and adverse events[J].Clin Microbiol Infect,2005,11 (8):682-683.
8Giamarellos-Buorboulis EJ,Xirouchaki E,Giamarellou H.Interaction of colistin and rifamipin on multidrug-resisstant Acinetobacter baumannii[J].Diagn Microbiol Infect Dis,2001,40(3):117-120.
9Michalopoulos AS,Tsiodras S,Rellos K,et al.Colistin treatment in patient with ICU-acquired infections caused by multiresistant Gram-negative bacteria:the renaissance of an old antibiotic[J].Clin Microbiol Infect,2005;11:115-121.
10Berlana D,Llop JM,Fort E,etal.Use of colistin in the treatment of multiple-drug-resistant gram-negative infections[J].Am J Health Syst Pharm,2005,62(1):39-47.
